Results 81 to 90 of about 34,408 (308)

Dienogest vs. combined oral contraceptive: A systematic review and meta‐analysis of efficacy and side effects to inform evidence‐based guidelines

open access: yesActa Obstetricia et Gynecologica Scandinavica, EarlyView.
Dienogest is comparable to combined oral contraceptives in terms of expected efficacy and tolerability profiles, showing no higher incidence rates of side effects such as irregular vaginal bleeding, nausea and vomiting, headache, hot flashes, and hair loss.
Ilaria Piacenti   +8 more
wiley   +1 more source

Adverse events reported for Mirena levonorgestrel‐releasing intrauterine device in France and impact of media coverage

open access: yesBritish Journal of Clinical Pharmacology, 2019
In 2017, concerns regarding adverse events (AEs) associated with the Mirena levonorgestrel intrauterine device were largely echoed in the media in France. This resulted in a tremendous reporting of AEs to pharmacovigilance centres.
C. Langlade   +7 more
semanticscholar   +1 more source

Differences in prescribing errors between electronic prescribing and traditional prescribing among medical students: A randomized pilot study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This randomized controlled pilot study aimed to assess the differences in the frequency, type and severity of prescribing errors made by medical students when assessed in an electronic (e‐)prescribing system compared to a traditional prescribing method (e.g., typing out a prescription).
Samir El Abdouni   +4 more
wiley   +1 more source

Dydrogesterone and norethisterone regulate expression of lipoprotein lipase and hormones-sensitive lipase in human subcutaneous abdominal adipocytes [PDF]

open access: yes, 2007
Aim: In premenopausal women, hyper-androgenicity is associated with central obesity and an increased cardiovascular risk. We investigated the effects of dydrogesterone (DYD)(a non-androgenic progestogen) and norethisterone (NET)(an androgenic progestogen)
Barnett, A. H.   +5 more
core   +1 more source

Changes of Body Mass Index and Lipid Profile in Injectable Depot Medroxyprogesterone Acetate and Levonorgestrel Implant Acceptors

open access: yesIndonesian Journal of Obstetrics and Gynecology, 2014
Objective: To determine the comparison of body mass index (BMI) among acceptors of injectable depot medroxyprogesterone acetate (DMPA) with levonorgestrel implant acceptors for 1 year and comparison of lipid profiles between depot medroxyprogesterone ...
Irwan Daido   +2 more
doaj   +1 more source

Are menstrual periods an environmental liability? Period poverty and eco‐feminist bioethics

open access: yesBioethics, EarlyView.
Abstract Period poverty has led to many initiatives across the world. In some places, period (or menstrual hygiene management [MHM]) products are free and readily found in restaurants, universities and pubs. However, conversations on mensuration management have also led to discussions on sustainability.
Cristina Richie
wiley   +1 more source

Perbedaan Profil Lipid pada Akseptor Depo Medroksi Progesteron Asetat dengan Implant Levonorgestrel di Wilayah Kerja Puskesmas Air Tawar Padang Tahun 2014

open access: yesJurnal Kesehatan Andalas, 2015
AbstrakDepo Medroksiprogesteron Asetat dan Implant Levonorgestrel merupakan kontrasepsi hormonal progestin sintetik yang memiliki efek samping yaitu peningkatan berat badan dan mempengaruhi metabolisme lipid. Tujuan penelitian ini adalah untuk mengetahui
Rafika Oktova, Desmiwarti ., Arni Amir
doaj  

Five-Year Contraceptive Efficacy and Safety of a Levonorgestrel 52-mg Intrauterine System

open access: yesObstetrics and Gynecology, 2018
A phase 3 study of a levonorgestrel 52-mg intrauterine system in U.S. females shows high 5-year contraceptive efficacy and low hormonal adverse effect rates.
S. Teal   +5 more
semanticscholar   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

RESECCIÓN ENDOMETRIAL HISTEROSCÓPICA MÁS INSERCIÓN DE DIU-LNG EN EL SANGRADO UTERINO ANORMAL REFRACTARIO A TRATAMIENTO MÉDICO

open access: yesRevista Chilena de Obstetricia y Ginecología, 2007
Objetivo: Evaluar los resultados del tratamiento del sangrado uterino anormal (SUA) refractario a tratamiento médico, con resección endometrial histeroscópica asociado a la inserción de un sistema intrauterino de liberación de levonorgestrel.
Juan Carlos Carvajal V   +3 more
doaj  

Home - About - Disclaimer - Privacy